Measurement of Hemodynamic Variables Under Spinal Anesthesia With Varied Positioning
1 other identifier
interventional
61
1 country
1
Brief Summary
Multiple studies have compared spinal anesthetic performed supine versus lateral, with varying results, in parturients having elective cesarean section. Needle positioning during spinal placement has also been examined. No positioning techniques have demonstrated definitive superiority for hemodynamic stability. Investigators propose that following spinal placement in the sitting position if the patient is placed in a lateral position for 90 seconds prior to turning them supine, hemodynamic changes caused by sympathectomy related to the subarachnoid block can be avoided. This is the first study to examining the influence of position changes after spinal anesthetic placement in the sitting position, which includes hemodynamic variables not previously studied including cardiac output, TPR (total peripheral resistance) and pulse pressure variation (PPV).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pregnancy
Started Aug 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 21, 2016
CompletedFirst Posted
Study publicly available on registry
August 30, 2016
CompletedStudy Start
First participant enrolled
August 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 26, 2018
CompletedFebruary 28, 2019
November 1, 2018
1.2 years
July 21, 2016
February 26, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Heart rate
Continuous Heart rate (beats per minute) measurements.
Immediately before spinal anesthestic placement through placental delivery
Blood pressure
Continuous Blood pressure (mmHg) measurements
Immediately before spinal anesthetic placement through placental delivery
Secondary Outcomes (7)
Incidence of nausea and vomiting
Number of events spinal anesthetic placement through placental delivery
Anti-emetic medication
Number of events spinal anesthetic placement through placental delivery
Incidence of vasopressor usage
Spinal anesthetic placement through placental delivery
Total vasopressor usage
Spinal anesthetic placement through placental delivery
Non Invasive Cardiovascular measurements: cardiac output
Spinal anesthetic placement through placental delivery
- +2 more secondary outcomes
Study Arms (3)
Supine position
SHAM COMPARATORSupine position Supine position after placement of spinal anesthetic
Right lateral position
ACTIVE COMPARATORRight lateral position Right lateral after placement of spinal anesthetic
Left lateral position
ACTIVE COMPARATORLeft lateral position Left lateral after placement of spinal anesthetic
Interventions
Spinal anesthesia in sitting position then 2 minutes in Supine position after spinal anesthetic administration
Spinal anesthesia in sitting position then 2 minutes in the right lateral position after spinal anesthetic administration
Spinal anesthesia in sitting position then 2 minutes in the left lateral position after spinal anesthetic administration
Eligibility Criteria
You may qualify if:
- Parturients undergoing elective cesarean section under spinal anesthesia
- Singleton intrauterine pregnancy with appropriate gestational age fetus (AGA) at gestational age 37 to 42 weeks
You may not qualify if:
- Large for gestational age, small for gestational age, and multiple gestations
- Patients with cardiovascular disease like hypertension, etc.
- Non-English or non-Spanish speakers
- BMI \>40
- Inadequate or failed blocks and inadvertently high levels of spinal blockade will be dropped from the study
- Incarcerated parturients
- Expected heavy bleeding (placenta accreta, vascular anomaly, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UTMB
Galveston, Texas, 77555, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ranganathan Govindaraj, MD, FRCA
The University of Texas Medical Branch, Galveston
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2016
First Posted
August 30, 2016
Study Start
August 1, 2017
Primary Completion
September 26, 2018
Study Completion
November 26, 2018
Last Updated
February 28, 2019
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share